home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
  HUM-MOLGEN -> Genetic News | search  

'Ethical' Stem Cells Under The Spotlight

  July, 2 2009 9:01
your information resource in human molecular genetics

Most, if not all, cell types in the body can be reprogrammed to become stem-cell-like, suggests a review of the so-called 'induced pluripotent stem (iPS) cells' in Nature. But complete and uniform reprogramming needs to be achieved if the resulting iPS cells are ever to be used in the clinic.

Shinya Yamanaka was the first to reprogram mature, differentiated cells into iPS cells, by using a retrovirus to add in a handful of genes. The cells, which can differentiate into many other cell types, were hailed as an ethical alternative to mainstream stem cell production methods that involve destroying embryos and require hard-to-come-by human eggs. However, the process of reprogramming is inefficient and often incomplete.

In this review, Yamanaka considers the reasons for bottlenecks in iPS cell production and proposes a model in which most or all cells have the potential to become stem-cell-like, given the right conditions - the reprogramming genes must be expressed in a particular pattern, and some other non-genetic events, such as methylation levels, are probably crucial. It's only when these factors can be reliably controlled that iPS cells are likely to achieve their full potential as key players in disease research, drug screening, toxicology and regenerative medicine.


Shinya Yamanaka (Kyoto University, Japan)
E-mail: yamanaka@frontier.kyoto-u.ac.jp

(C) Nature press release.

Message posted by: Trevor M. D'Souza

print this article mail this article
Latest News
Variants Associated with Pediatric Allergic Disorder

Mutations in PHF6 Found in T-Cell Leukemia

Genetic Risk Variant for Urinary Bladder Cancer

Antibody Has Therapeutic Effect on Mice with ALS

Regulating P53 Activity in Cancer Cells

Anti-RNA Therapy Counters Breast Cancer Spread

Mitochondrial DNA Diversity

The Power of RNA Sequencing

‘Pro-Ageing' Therapy for Cancer?

Niche Genetics Influence Leukaemia

Molecular Biology: Clinical Promise for RNA Interference

Chemoprevention Cocktail for Colon Cancer

more news ...

Generated by News Editor 2.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2023 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.